Exogenous Cushing's syndrome and topical ocular steroids [1]

Eye

Volumn 20, Issue 6, 2006, Pages 725-727

  Chiang, M Y M ^a   Sarkar, M ^b   Koppens, J M ^a   Milles, J ^b   Shah, P ^a  

^a CITY HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; METHOTREXATE; METHYLPREDNISOLONE; MITOMYCIN C; PREDNISOLONE ACETATE; STEROID; TETRACOSACTIDE;

ADULT; CASE REPORT; CATARACT; CUSHING SYNDROME; ENDOCRINE OPHTHALMOPATHY; GLAUCOMA; HUMAN; INTRAOCULAR HYPERTENSION; LETTER; MALE; MOON FACE; OBESITY; OPHTHALMOSCOPY; PROVOCATION TEST; SLIT LAMP; TRABECULECTOMY; UVEITIS; VISUAL ACUITY; WEIGHT GAIN;

EID: 33745084951     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/sj.eye.6701956     Document Type: Letter

References (6)

1. Wilson AM, Blumsohn A, Jung RT, Lipworth BJ. Asthma and Cushing's syndrome. Chest 2000; 117: 593-594.
2. Homer JJ, Gazis TG. Cushing's syndrome induced by betamethasone nose drops. In rhinological disease betamethasone should be regarded as systemic corticosteroid. BMJ 1999; 318: 1355.
3. Ozerdem U, Levi L, Cheng L, Song MK, Scher C, Freeman WR. Systemic toxicity of topical and periocular corticosteroid therapy in an 11-year-old male with posterior uveitis. Am J Ophthalmol 2000; 130: 240-241.
4. Romano PE, Traisman HS, Green OS. Fluorinated corticosteroid toxicity in infants. Am J Ophthalmol 1977; 84: 249-250.
5. Frey FJ, Amend Jr WJ, Lozada F, Frey BM, Benet LZ. Endogenous hydrocortisone, a possible factor contributing to the genesis of cushingoid habitus in patients on prednisone. J Clin Endocrinol Metab 1981; 53: 1076-1080.
6. Tuel SM, Meythaler JM, Cross LL. Cushing's syndrome from epidural methylprednisolone. Pain 1990; 40: 81-84.